☰

Gary Aston-Jones

Affiliations: 
Medical University of South Carolina, Charleston, SC, United States 
Area:
neuropharmacology
Google:
"Gary Aston-Jones"
Mean distance: 11.85 (cluster 40)
 		SNBCP
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
James Olds grad student MUSC
Stuart H. Thompson grad student Stanford
Simon Alford post-doc MUSC
Floyd E. Bloom post-doc The Salk Institute for Biological Studies

Children

Sign in to add trainee
Mathieu E. Wimmer research assistant 2003-2006 Penn
Rebecca V Fallon research assistant 2008-2011 MUSC
Noam I. Keren grad student MUSC
Mark A Presker grad student Rutgers - Robert Wood Johnson Medical School
Elisabeth J. VanBockstaele grad student Thomas Jefferson Univ
Alice Hsueh Luo grad student 2007 Penn
Rachel Joann Smith grad student 2008 Penn
Gregory C. Sartor grad student 2007-2011 MUSC
Brandon S. Bentzley grad student 2014 MUSC
Zackary A. Cope grad student 2014 MUSC
Brittney M. Cox grad student 2010-2015 MUSC
Andrea Bari post-doc MUSC
Heinrich S. Gompf post-doc MUSC
Kirsten A. Porter-Stransky post-doc MUSC
Pouya Tahsili-Fahadan post-doc Medical University of SC
David Moorman post-doc 2006- MUSC
Matthew D. Riedy post-doc 2009- MUSC
Elena Maria Vazey post-doc 2009- MUSC
Benjamin A. Zimmer post-doc 2013- MUSC
Amy S. Kohtz post-doc 2014- Rutgers, New Brunswick
Mohsen Omrani post-doc 2015- Rutgers, New Brunswick
Michael  L. Oshinsky post-doc 1998-2000 Children’s Hospital of Philadelphia / University of Pennsylvania
Stephen V. Mahler post-doc 2009-2015 MUSC

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Freeman LR, Bentzley BS, James MH, et al. (2020) Sex Differences in Demand for Highly Palatable Foods: Role of the Orexin System. The International Journal of Neuropsychopharmacology
James MH, Fragale JE, Aurora RN, et al. (2020) Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
James MH, Aston-Jones G. (2020) Introduction to the Special Issue: "Orexin/hypocretin receptor antagonists for the treatment of addiction and related psychiatric disease: What are the steps from here?" Brain Research. 146665
Gu Y, Piper WT, Branigan LA, et al. (2019) A brainstem-central amygdala circuit underlies defensive responses to learned threats. Molecular Psychiatry
Hamlett ED, Ledreux A, Gilmore A, et al. (2019) Inhibitory designer receptors aggravate memory loss in a mouse model of down syndrome. Neurobiology of Disease. 134: 104616
Mohammadkhani A, Fragale JE, Pantazis CB, et al. (2019) Orexin-1 receptor signaling in ventral pallidum regulates motivation for the opioid remifentanil. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Mohammadkhani A, James MH, Pantazis CB, et al. (2019) Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil. Brain Research. 146461
Pantazis CB, James MH, Bentzley BS, et al. (2019) The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand. Addiction Biology. e12795
Fragale JE, Pantazis CB, James MH, et al. (2019) The role of orexin-1 receptor signaling in demand for the opioid fentanyl. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Wiskerke J, James MH, Aston-Jones G. (2019) The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task. Brain Research
See more...